Advertisement

5 Responses

  1. Joe
    Joe August 6, 2014 at 5:12 am | | Reply

    Barbie rep, I love it. I’ve seen a few of those in my day when working in Doctors offices. They only thing they are good for in my opinion is bringing free lunches for the office staff.

  2. Brian (bsc)
    Brian (bsc) August 6, 2014 at 5:41 am | | Reply

    I am actually hoping that this pen will be easier to use for me, not because of the larger max injection but because it will make injecting harder to reach sites easier. I actually find the current flexpen at times hard to inject due to the force required, perhaps it is due to the viscosity of the Levemir. I’m hoping that the mechanism will require less force.

    I’d also like to correct two things. First, Levemir has stated the opened vials, pens and cartridges are good for 42 days after opening for years, this has been a “selling point” for Levemir. So there is no change there, Levemir is still Levemir, the 42 days has nothing to do with the pen.

    And second, the Flextouch is a replacement for the Flexpen, it isn’t an alternate product. According to Lilly, the Flexpen will no longer be available after October.

  3. mcityrk
    mcityrk August 7, 2014 at 9:34 am | | Reply

    Saw a tv ad for this yesterday. The 42 to 28 day comparison was lantus versus levemir.

  4. Scott S
    Scott S August 11, 2014 at 9:27 am | | Reply

    The reality is this: the new pen enables Novo to delivery significantly higher dosages than the old pen. Novo, Sanofi and Lilly are all pursuing ever more concentrated insulin varieties (U200, U300, etc.) (I blogged about when these announcements first emerged back in June 2013, see my post at http://goo.gl/yFbllW), with the target market being the large and rapidly-growing type 2 audience. But the salespeople at these conferences aren’t the brightest bulbs in the boxes. She seems ignorant to the fact that insurance formularies, and not the medical professionals or the patients, are the only real buyers who matter. Novo, for its part, wants more type 2s to use insulin, so its working to make that easier.

  5. Ron B
    Ron B December 11, 2014 at 3:24 pm | | Reply

    I like the FlexTouch Levemir Pen so well, I would like to know when NovoLog will be available in the FlexTouch delivery system.

Leave a Reply